Economic Models

Costo efectividad de la vacunación contra influenza en menores de 2 años y mayores de 65 años en Colombia

Economics / Colombia / Cancer / Australia / Quality of life / Risk / Forecasting / Argentina / Treatment Outcome / Decision Analysis / Health Policy / Pharmacoeconomics / Adolescent / Prevention / Israel / Biological Sciences / Decision Trees / Humans / Child / Age / Pneumonia / Young Adult / Infant / Vaccine / Cost effectiveness / Life Expectancy / Incidence / Vaccination / Discount Rate / Risk factors / Newborn Infant / Aged / Middle Aged / Quality adjusted life years / Adult / Economic Models / Cost Benefit Analysis / Retrospective Studies / Age Factors / Economic evaluation / Influenza Vaccine / Risk Factors / Vaccine Effectiveness / Older Adult / Cost of Illness / Health Care Costs / Age Groups / Nino / Immunization Programs / Child preschool / Risk / Forecasting / Argentina / Treatment Outcome / Decision Analysis / Health Policy / Pharmacoeconomics / Adolescent / Prevention / Israel / Biological Sciences / Decision Trees / Humans / Child / Age / Pneumonia / Young Adult / Infant / Vaccine / Cost effectiveness / Life Expectancy / Incidence / Vaccination / Discount Rate / Risk factors / Newborn Infant / Aged / Middle Aged / Quality adjusted life years / Adult / Economic Models / Cost Benefit Analysis / Retrospective Studies / Age Factors / Economic evaluation / Influenza Vaccine / Risk Factors / Vaccine Effectiveness / Older Adult / Cost of Illness / Health Care Costs / Age Groups / Nino / Immunization Programs / Child preschool

A Method for a Comparison of Bulk Energy Transport Systems

Environmental Science / Air Quality / Modeling / Transportation / Intelligent Transport System / Sensitivity Analysis / Multidisciplinary / Environmental science and technology / Visibility / Electromagnetic Field / Economic Models / Coal Mine / Costs and Cost Analysis / Sensitivity Analysis / Multidisciplinary / Environmental science and technology / Visibility / Electromagnetic Field / Economic Models / Coal Mine / Costs and Cost Analysis

Pago por desempeño explicado desde la teoría de costos de transacción

Colombia / Transaction Costs / Health Care / Health insurance / Health Services / Hospitalization / Incentives / Transaction Cost Theory / Economic Models / Transaction Cost / Pay for performance / Ambulatory Care / Costs and Cost Analysis / Hospitalization / Incentives / Transaction Cost Theory / Economic Models / Transaction Cost / Pay for performance / Ambulatory Care / Costs and Cost Analysis

A Method for a Comparison of Bulk Energy Transport Systems

Environmental Science / Air Quality / Modeling / Transportation / Intelligent Transport System / Sensitivity Analysis / Multidisciplinary / Environmental science and technology / Visibility / Electromagnetic Field / Economic Models / Coal Mine / Costs and Cost Analysis / Sensitivity Analysis / Multidisciplinary / Environmental science and technology / Visibility / Electromagnetic Field / Economic Models / Coal Mine / Costs and Cost Analysis

A Method for a Comparison of Bulk Energy Transport Systems

Environmental Science / Air Quality / Modeling / Transportation / Intelligent Transport System / Sensitivity Analysis / Multidisciplinary / Environmental science and technology / Visibility / Electromagnetic Field / Economic Models / Coal Mine / Costs and Cost Analysis / Sensitivity Analysis / Multidisciplinary / Environmental science and technology / Visibility / Electromagnetic Field / Economic Models / Coal Mine / Costs and Cost Analysis

Common ecology quantifies human insurgency

Physics / Complex Systems Science / Terrorism / Decision Making / Violence / Colombia / Afghanistan / Insurgency/Counterinsurgency(COIN) / Ecology / Iraq / Asymmetrical Warfare / Irregular Warfare / Group Processes / Intergroup Conflict (Psychology) / Multidisciplinary / Nature / War / Humans / New Wars Debate / Human Behaviour / Financial Market / Decision making process / Self Organization / Size Distribution / Time Factors / Economic Models / Unified Model / Human Activity / Power Law Distribution / Colombia / Afghanistan / Insurgency/Counterinsurgency(COIN) / Ecology / Iraq / Asymmetrical Warfare / Irregular Warfare / Group Processes / Intergroup Conflict (Psychology) / Multidisciplinary / Nature / War / Humans / New Wars Debate / Human Behaviour / Financial Market / Decision making process / Self Organization / Size Distribution / Time Factors / Economic Models / Unified Model / Human Activity / Power Law Distribution

Common ecology quantifies human insurgency

Physics / Complex Systems Science / Terrorism / Decision Making / Violence / Colombia / Afghanistan / Insurgency/Counterinsurgency(COIN) / Ecology / Iraq / Asymmetrical Warfare / Irregular Warfare / Group Processes / Intergroup Conflict (Psychology) / Multidisciplinary / Nature / War / Humans / New Wars Debate / Human Behaviour / Financial Market / Decision making process / Self Organization / Size Distribution / Time Factors / Economic Models / Unified Model / Human Activity / Power Law Distribution / Colombia / Afghanistan / Insurgency/Counterinsurgency(COIN) / Ecology / Iraq / Asymmetrical Warfare / Irregular Warfare / Group Processes / Intergroup Conflict (Psychology) / Multidisciplinary / Nature / War / Humans / New Wars Debate / Human Behaviour / Financial Market / Decision making process / Self Organization / Size Distribution / Time Factors / Economic Models / Unified Model / Human Activity / Power Law Distribution

Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA para el tratamiento antirretroviral inicial

Expert testimony / Clinical Trial / Medical Microbiology / Treatment Outcome / Spain / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic

Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA para el tratamiento antirretroviral inicial

Expert testimony / Clinical Trial / Medical Microbiology / Treatment Outcome / Spain / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic

Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA/Plan Nacional sobre el Sida en 2012 para el tratamiento antirretroviral inicial en adultos infectados por el virus de la inmunodeficiencia humana (VIH)

Expert testimony / Clinical Trial / Medical Microbiology / Treatment Outcome / Spain / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic

Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA para el tratamiento antirretroviral inicial

Expert testimony / Clinical Trial / Medical Microbiology / Treatment Outcome / Spain / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic

Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA/Plan Nacional sobre el Sida en 2012 para el tratamiento antirretroviral inicial en adultos infectados por el virus de la inmunodeficiencia humana (VIH)

Expert testimony / Clinical Trial / Medical Microbiology / Treatment Outcome / Spain / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic

Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA/Plan Nacional sobre el Sida en 2013 para el tratamiento antirretroviral inicial en adultos infectados por el virus de la inmunodeficiencia humana

Expert testimony / Clinical Trial / Medical Microbiology / Treatment Outcome / Spain / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic

Material flows and economic models: an analytical comparison of SFA, LCA and partial equilibrium models

Ecological Economics / Life Cycle Assessment / Applied Economics / Economic Models / Flow analysis / Economic Model / Substance Flow Analysis / ENVIRONMENTAL SCIENCE AND MANAGEMENT / Economic Model / Substance Flow Analysis / ENVIRONMENTAL SCIENCE AND MANAGEMENT

Generous economic investments after basolateral amygdala damage

Decision Making / Experimental games / Trust / Multidisciplinary / Humans / Amygdala / Economic Models / Choice Behavior / Socioeconomic Factors / Amygdala / Economic Models / Choice Behavior / Socioeconomic Factors

Costo-Efectividad del Cardiodesfibrilador Implantable en Pacientes con Factores de Riesgo de Muerte Súbita en Argentina

Quality of life / Argentina / Treatment Outcome / Public Health / Risk assessment / Social Security / Applied Economics / Sudden Death / Humans / Markov chains / Cost effectiveness / Risk factors / Public health systems and services research / Economic Models / Cost Benefit Analysis / Private Sector / Sudden Cardiac Death / Health Care Utilization / Risk Factors / Risk Assessment / Implantable defibrillators-cardioverters / Health Care Costs / Social Security / Applied Economics / Sudden Death / Humans / Markov chains / Cost effectiveness / Risk factors / Public health systems and services research / Economic Models / Cost Benefit Analysis / Private Sector / Sudden Cardiac Death / Health Care Utilization / Risk Factors / Risk Assessment / Implantable defibrillators-cardioverters / Health Care Costs
Copyright © 2017 DATOSPDF Inc.